The global market for Molecular Diagnostics is estimated at US$14.9 Billion in 2023 and is projected to reach US$27.0 Billion by 2030, growing at a CAGR of 8.9% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
The growth in the molecular diagnostics market is driven by several factors, including technological advancements, increasing prevalence of infectious diseases and cancer, rising demand for personalized medicine, and greater health awareness among consumers. The integration of high-throughput sequencing technologies has dramatically increased the capability and affordability of genetic testing, making it accessible to a broader population. This accessibility is crucial for the early detection of diseases and for tailoring specific therapies to individuals, which is at the heart of personalized medicine. Additionally, the global rise in health consciousness and preventive healthcare measures has heightened demand for these diagnostics.
Governments and healthcare institutions are also recognizing the value of molecular diagnostics in improving health outcomes, leading to greater investment in this technology. Moreover, the ongoing development of more sophisticated data analysis tools has enabled the extraction of more detailed insights from genetic data, further propelling the market forward. These factors collectively ensure sustained growth and continual innovation within the field of molecular diagnostics.
The growth in the molecular diagnostics market is driven by several factors, including technological advancements, increasing prevalence of infectious diseases and cancer, rising demand for personalized medicine, and greater health awareness among consumers. The integration of high-throughput sequencing technologies has dramatically increased the capability and affordability of genetic testing, making it accessible to a broader population. This accessibility is crucial for the early detection of diseases and for tailoring specific therapies to individuals, which is at the heart of personalized medicine. Additionally, the global rise in health consciousness and preventive healthcare measures has heightened demand for these diagnostics.
Governments and healthcare institutions are also recognizing the value of molecular diagnostics in improving health outcomes, leading to greater investment in this technology. Moreover, the ongoing development of more sophisticated data analysis tools has enabled the extraction of more detailed insights from genetic data, further propelling the market forward. These factors collectively ensure sustained growth and continual innovation within the field of molecular diagnostics.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Molecular Diagnostics Reagents & Kits segment, which is expected to reach US$16.0 Billion by 2030 with a CAGR of a 9.5%. The Molecular Diagnostics Instruments segment is also set to grow at 8.0% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $6.3 Billion in 2023, and China, forecasted to grow at an impressive 10.2% CAGR to reach $1.6 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Molecular Diagnostics Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Molecular Diagnostics Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Molecular Diagnostics Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as Abbott Laboratories, Inc., Agilent Technologies, Inc., Becton, Dickinson and Company, and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 84 Featured):
- Abbott Laboratories, Inc.
- Agilent Technologies, Inc.
- Becton, Dickinson and Company
- Beckman Coulter, Inc.
- Asuragen, Inc.
- Analytik Jena AG
- A. Menarini Diagnostics Srl
- Abaxis, Inc.
- Agena Bioscience, Inc.
- Advanced Cell Diagnostics, Inc.
- AutoGenomics, Inc.
- Akonni Biosystems, Inc.
- Berg LLC
- Agendia, Inc.
- BioAgilytix Labs
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISCANADAITALYSPAINRUSSIAREST OF EUROPESOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
AUSTRALIA
INDIA
LATIN AMERICA
MIDDLE EAST
AFRICA
Companies Mentioned
- Abbott Laboratories, Inc.
- Agilent Technologies, Inc.
- Becton, Dickinson and Company
- Beckman Coulter, Inc.
- Asuragen, Inc.
- Analytik Jena AG
- A. Menarini Diagnostics Srl
- Abaxis, Inc.
- Agena Bioscience, Inc.
- Advanced Cell Diagnostics, Inc.
- AutoGenomics, Inc.
- Akonni Biosystems, Inc.
- Berg LLC
- Agendia, Inc.
- BioAgilytix Labs
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 880 |
| Published | December 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 14.9 Billion |
| Forecasted Market Value ( USD | $ 27 Billion |
| Compound Annual Growth Rate | 8.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 15 |
